Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia
Open Access
- 20 January 2004
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 19 (3) , 349-358
Abstract
Background : Adult Helicobacter pylori‐positive patients by 13C‐urea breath test with uninvestigated dyspepsia symptoms were randomized to 1‐week eradication treatment with omeprazole, metronidazole and clarithromycin (OMC) vs. omeprazole and placebo antimicrobials (OPP) in the Canadian Adult Dyspepsia Empiric Treatment—H. pylori‐positive (CADET‐Hp) study. Aim : To perform an economic evaluation of this 1‐year study. Methods : Following blind eradication treatment, family practitioners managed patients according to their usual practices. Health resource utilization information was collected prospectively. From the mean costs of the health resources consumed and the treatment outcomes, the incremental cost‐effectiveness ratios and incremental net benefits of eradication treatment vs. OPP were determined. Results : Eradication therapy significantly improved dyspepsia symptoms (treatment success: OMC, 50%; OPP, 36%; P = 0.02). The incremental cost‐effectiveness ratio of OMC vs. OPP was − 387 Canadian dollars (CAD$) per treatment success (90% CI, – CAD$1707, CAD$607), indicating a lower cost with treatment success. The incremental net benefit analysis showed that H. pylori eradication was cost‐effective if the willingness‐to‐pay value exceeded a nominal figure of CAD$100 from a health service perspective or CAD$607 from the societal perspective. Conclusion : In uninvestigated patients presenting with dyspepsia at the primary care level, eradication of H. pylori in those who are H. pylori positive leads to a cost‐effective improvement in dyspepsia symptoms compared with a strategy of not eradicating H. pylori in these patients.Keywords
This publication has 27 references indexed in Scilit:
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus ReportAlimentary Pharmacology & Therapeutics, 2002
- Recurrent diarrhoea and weight loss associated with cessation of smoking in a patient with undiagnosed coeliac diseaseGut, 2001
- Incremental net benefit in randomized clinical trialsStatistics in Medicine, 2001
- Therapy for Helicobacter pylori in Patients with Nonulcer DyspepsiaAnnals of Internal Medicine, 2001
- Analysis of cost data in randomized trials: an application of the non-parametric bootstrapStatistics in Medicine, 2000
- The management of dyspepsia: a systematic review.Health Technology Assessment, 2000
- A prospective randomised trial of a “test and treat” policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinicGut, 1999
- The Report of the Digestive Health InitiativesSM International Update Conference on Helicobacter pyloriGastroenterology, 1997
- clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer diseaseAlimentary Pharmacology & Therapeutics, 1996
- A survey of dyspepsia in Great BritainAlimentary Pharmacology & Therapeutics, 1996